Molecular Immunology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
The Molecular Immunology section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish original contributions addressing questions of importance in immunology and related fields. We welcome manuscripts conveying novel experimental findings that would advance understanding of molecular mechanisms of immunity, immunogenetics and/or immunopathogenesis. Manuscripts reporting development or testing of novel therapeutics that target molecular mechanisms are likewise sought. Manuscripts reviewing topics pertinent to the scope of the Molecular Immunology Section will be considered if the manuscripts offer analysis of existing knowledge and/or a perspective that is not otherwise available.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Protective Immune Response to Virus Infection and Vaccines (Deadline: 15 December 2023)
- Tumor Immune Microenvironment and Immunotherapy: Novel Insights and Future Perspectives in HCC (Deadline: 15 December 2023)
- Molecular Insight into Pharmacological Research on Anti-inflammatory Immunity (Deadline: 15 December 2023)
- New Molecular Mechanisms and Markers in Inflammatory Disorders, 2nd Edition (Deadline: 20 December 2023)
- Molecular Mechanisms Regulating Central and Peripheral Immunity in Neurodegenerative Diseases (Deadline: 20 December 2023)
- Intercommunication between Immune Cells and Mesenchymal Stem Cells in Regenerative Medicine (Deadline: 30 December 2023)
- Osteoimmunology in Rheumatic Diseases (Deadline: 30 December 2023)
- Mucosal Delivery of Vaccines (Deadline: 30 December 2023)
- Recent Advances in Autoimmune and Inflammatory Disorders (Deadline: 30 December 2023)
- The Research on Immune Responses Regulating Molecules in Cancer Development, Progression and Treatment (Deadline: 30 December 2023)
- Role of Cytokines and Their Receptors in Human Tumors and Immune-Regulation (Deadline: 30 December 2023)
- Platelet Activation in Human Health and Disease (Deadline: 30 December 2023)
- Advanced Research on Macrophages in Human Health and Disease (Deadline: 30 December 2023)
- Progression of Allergy and Immune Response (Deadline: 31 December 2023)
- Cellular and Molecular Immune Research on Renal Transplantation (Deadline: 31 December 2023)
- Immunometabolic Disorders in Aging and Disease (Deadline: 31 December 2023)
- Innate and Adaptive Immunity in COVID-19 (Deadline: 31 December 2023)
- Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus 2.0 (Deadline: 31 December 2023)
- Insights in Reproductive Immunology and Placental Pathology (Deadline: 31 December 2023)
- Immune Functions of Astrocytes (Deadline: 31 December 2023)
- Molecular Mechanisms of Gastrointestinal Immune System and Its Role in Gut Homeostasis and Pathologies (Deadline: 31 December 2023)
- Mechanisms of Immune Evasion by High-Grade Gliomas and the Development of Immunotherapy (Deadline: 31 December 2023)
- Effect of Apolipoprotein on Bacterial Infections (Deadline: 31 December 2023)
- Arthritis and Inflammatory Cytokine 2.0 (Deadline: 31 December 2023)
- Development of Vaccines against Arboviruses (Deadline: 31 December 2023)
- Cytokines in Inflammatory Signaling (Deadline: 31 December 2023)
- State-of-the-Art Cancer Immunotherapies (Deadline: 31 December 2023)
- Advanced Research on Immune Cells and Cytokines (Deadline: 31 December 2023)
- Research Advances in Immunogenetics (Deadline: 31 December 2023)
- The Promising Future of CAR-Based Therapies: A Matter of Molecular Details (Deadline: 31 December 2023)
- Dendritic Cell and Cancer Therapy 2.0 (Deadline: 10 January 2024)
- Advances in Hematological Disorders: New Insights and Novel Methods (Deadline: 10 January 2024)
- Crosstalk between Lipids and Immunity (Deadline: 15 January 2024)
- The Twist and Turn of Lipids in Human Diseases 2.0 (Deadline: 15 January 2024)
- Multiple Sclerosis at the Crossroads of Autoimmunity and Neurodegeneration 2.0 (Deadline: 30 January 2024)
- Deciphering Allergies—Structural and Immunological Characterization of Allergenic Proteins and Immunomodulatory Agents (Deadline: 30 January 2024)
- The Road to Tolerance: Mechanism of Immune Homeostasis in Health and Disease (Deadline: 30 January 2024)
- Advance Research in Immuno-Oncology Drug Development (Deadline: 30 January 2024)
- New Advances in Molecular Research of Coronavirus (Deadline: 30 January 2024)
- Inflammation, Fibrosis and Neovascularisation: New Perspectives for Old Foes in the Pathogenesis of Neovascular AMD (Deadline: 30 January 2024)
- Recent Advances in the Immunopathology, Diagnostic Biomarkers, Susceptibility and Potential Therapies for Adverse Reactions to Food (Deadline: 30 January 2024)
- Molecular Biology of the Immune System in Systemic Autoimmune Diseases (Deadline: 30 January 2024)
- Molecular Mechanisms at the Intersection of Protein Synthesis, Cancer, and Immunity (Deadline: 31 January 2024)
- Updates in Cell and Molecular Mechanisms of Autoimmune Diseases 2.0 (Deadline: 31 January 2024)
- Inflammatory Tissue Response—How Nature Fights Back (Deadline: 31 January 2024)
- The Role of T Cells in Immunomodulation: Focus on Molecular Mechanisms (Deadline: 31 January 2024)
- Human Immunodeficiency Virus-1 Infection: Molecular and Cellular Immunity (Deadline: 31 January 2024)
- New Insights in Tumor Immunity (Deadline: 31 January 2024)
- New Insights into Gut Microbiota and Immunity (Deadline: 31 January 2024)
- Molecular Mechanisms of Endothelial Dysfunction 3.0 (Deadline: 31 January 2024)
- Macrophages in Human Diseases and Their Treatment (Deadline: 31 January 2024)
- Mast Cells in Immunity and Diseases (Deadline: 31 January 2024)
- New Insights into Lipids and Immune Responses (Deadline: 31 January 2024)
- Molecular Targets and Immunotherapy for Autoimmune Diseases (Deadline: 31 January 2024)
- Vaccine Research and Adjuvant Discovery (Deadline: 31 January 2024)
- Molecular Advances in Gut Microbiota and Its Interaction with Immune System (Deadline: 10 February 2024)
- Oral Medicine and Immunity 2.0 (Deadline: 15 February 2024)
- Immune-Mediated Cholangitis: Advances of Pathogenesis and Therapeutics (Deadline: 15 February 2024)
- Editorial Board Members’ Collection Series: Autoimmune Diseases (Deadline: 15 February 2024)
- Neuroinflammation in the Pathogenesis of Alzheimer's Disease and Related Dementias (Deadline: 15 February 2024)
- Molecular Advances in Biotechnological Approaches to Developing Effective Antimicrobial Agents (Deadline: 15 February 2024)
- Cellular and Viral Immunology of HIV-1 Infection: An Update (Deadline: 20 February 2024)
- Viral and Bacterial Infections in Older Adults: From Mechanisms to Therapies (Deadline: 22 February 2024)
- Diverse Responses of Immune Cells to Bacterial Infections (Deadline: 28 February 2024)
- Molecular Biology and Immunological Advances in Hematological Malignancies (Deadline: 28 February 2024)
- Molecular Mechanisms of Periodontal Disease and Autoimmune Diseases (Deadline: 28 February 2024)
- Advances in Endothelial Cell Biology 3.0 (Deadline: 28 February 2024)
- Advanced Research on the Immune Microenvironment in Tumors (Deadline: 28 February 2024)
- Role of Immune Cells in Non-infectious Inflammatory Diseases and Cancers (Deadline: 28 February 2024)
- Insights into Viral Pathogenesis: Host Antiviral Responses and Viral Countermeasures (Deadline: 28 February 2024)
- Immunotherapy of Brain Tumor (Deadline: 29 February 2024)
- Harnessing the Iatrogenic Autoimmune Forces by an Off-Label Low-Dose Combined Anti-CTLA-4 Plus Anti-PD-1 Antibody Blockade (Deadline: 29 February 2024)
- DNA-Based Vaccines against Infectious Diseases and Cancer (Deadline: 29 February 2024)
- Immunomodulatory Molecules in Cancer (Deadline: 29 February 2024)
- Cytokines in Immune Diseases (Deadline: 29 February 2024)
- Molecular Immunology of Solid Tumors 2.0 (Deadline: 29 February 2024)
- Immunotherapy: New Developments and Challenges (Deadline: 29 February 2024)
- Chronic Rhinosinusitis: Aetiology, Immunology and Treatment 2.0 (Deadline: 29 February 2024)
- Recent Advances in Immunobiology in Colorectal Cancer (Deadline: 29 February 2024)
- Recent Advances in Neutrophil Extracellular Traps (NETs) (Deadline: 29 February 2024)
- Autoimmune Diseases: A Swing Dance of Immune Cells 2.0 (Deadline: 29 February 2024)
- Molecular Basis and Progress of Immunotherapy for Melanoma (Deadline: 29 February 2024)
- Neutrophil in Cell Biology and Diseases 2.0 (Deadline: 15 March 2024)
- Targeted Therapy for Immune Diseases (Deadline: 15 March 2024)
- The Immune System as a Target for Therapy of Progressive Multiple Sclerosis (MS) in Patients and Animal Models (Deadline: 15 March 2024)
- New Insights into Immune and Anti-inflammatory Strategies for Improving Human Health (Deadline: 15 March 2024)
- Novel Immunomodulatory Approaches for Lung Fibrosis (Deadline: 15 March 2024)
- Immunophenotyping in Autoimmune Diseases and Cancer, 4th Edition (Deadline: 20 March 2024)
- The Role of Immune System in Tissue Repair and Regeneration (Deadline: 28 March 2024)
- Infection and the Kidney 2.0 (Deadline: 30 March 2024)
- Pro-inflammatory and Anti-inflammatory Interleukins in Various Diseases 2.0 (Deadline: 30 March 2024)
- Cellular and Molecular Mechanisms of Severe Combined Immunodeficiencies (SCID): From Newborn Screening to Treatment Innovations (Deadline: 30 March 2024)
- New Insights into Lactoferrin (Deadline: 30 March 2024)
- Signaling Mechanisms in Orchestrating Host Immune Responses: An Update (Deadline: 30 March 2024)
- Diseases of the Lymphatic System: Pathophysiology and Molecular Imaging (Deadline: 30 March 2024)
- Immunotherapy: A New Perspective in Cancer Treatment (Deadline: 30 March 2024)
- Beta Thymosins: The Role in Immunity, Organ Regeneration, Development and Aging (Deadline: 30 March 2024)
- The Role of Proteases and Protease Inhibitors in the Immune System (Deadline: 31 March 2024)
- Immunomodulatory Activities of Natural Products and Related Compounds in Inflammatory Diseases (Deadline: 31 March 2024)
- Virus–Host Interaction and Cell Restriction Mechanisms 2.0 (Deadline: 31 March 2024)
- Interactions Between the Environment and the Intestinal Epithelium: Gut Barrier Function and Inflammation (Deadline: 31 March 2024)
- Drug Hypersensitivity Reactions and Pseudoallergy: A Moving Frontline in Allergy Research (Deadline: 31 March 2024)
- Roles of Mast Cells in Immune-Induced Diseases (Deadline: 31 March 2024)
- Molecular Research of Viral Gastroenteritis (Deadline: 31 March 2024)
- The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0 (Deadline: 31 March 2024)
- Molecular Mechanisms of Treating Psoriasis (Deadline: 31 March 2024)
- Activation and Modulation of Mast Cells. An Update on Respiratory Physiological and Pathological Conditions (Deadline: 10 April 2024)
- Insights into Cytotoxic Lymphocytes Maintaining Immune Homeostasis (Deadline: 10 April 2024)
- Influenza Viruses: Infection and Genomics (Deadline: 15 April 2024)
- Immune Response in Atopic Dermatitis (Deadline: 15 April 2024)
- Regulation and Activation of Immune Cells through the Mitochondria (Deadline: 15 April 2024)
- Alcohol and Inflammation (Deadline: 15 April 2024)
- Macrophage Polarization: Learning to Manage It 3.0 (Deadline: 15 April 2024)
- Artificial Intelligence and Immune-Mediated Diseases (Deadline: 15 April 2024)
- New Targeted Therapeutic Strategies of Multiple Myeloma (Deadline: 18 April 2024)
- State-of-the-Art Molecular Immunology in Japan (Deadline: 18 April 2024)
- Advances in Experimental and Clinical Aspects of Allergies and Autoimmunity (Deadline: 20 April 2024)
- Drug-Induced Modulation and Immunotherapy of Leukemia (Deadline: 20 April 2024)
- Pathogenesis and Management of Mastocytosis (Deadline: 20 April 2024)
- Novel Molecular Research in Skin Inflammation (Deadline: 20 April 2024)
- Immune-Inflammatory and Oxidative Stress Signaling Pathways Involved in Human Disorders (Deadline: 28 April 2024)
- Physiological Benefits of Dietary Selenium (Deadline: 29 April 2024)
- The Role of Inflammasomes in Human Disease (Deadline: 30 April 2024)
- Inflammatory Disturbances in Cerebrovascular and Cardiovascular Diseases (Deadline: 30 April 2024)
- Immunotherapy for Cancer 2023 (Deadline: 30 April 2024)
- Roles of Inflammasomes in Inflammatory Responses and Human Diseases (Deadline: 30 April 2024)
- Insights in Multiple Sclerosis (MS) and Neuroimmunology (Deadline: 30 April 2024)
- Immunopathology, Vaccine Development and Treatment of Viruses (Deadline: 30 April 2024)
- Inflammatory Responses and Immunity under Stress (Deadline: 30 April 2024)
- The Role of Neutrophils in Inflammatory Diseases (Deadline: 30 April 2024)
- Molecular and Therapeutic Research in Rheumatoid Arthritis (Deadline: 30 April 2024)
- Antimicrobial Peptides, Cytokines, Chemokines and Danger Molecules in Immunity and Autoimmunity (Deadline: 30 April 2024)
- Editorial Board Members’ Collection Series: “Neuroinflammation” (Deadline: 30 April 2024)
- Immune Mechanisms and Biomarkers in Systemic Lupus Erythematosus (Deadline: 30 April 2024)
- TRP Channels in Pain and Inflammation 2.0 (Deadline: 30 April 2024)
- Advanced Research on Immune Response to Viral Infection (Deadline: 30 April 2024)
- Molecular Linkage between Cardiovascular Diseases and Immune System Disorders (Deadline: 30 April 2024)
- Inflammatory Diseases, Dysbiosis and Infections (Deadline: 30 April 2024)
- Immunology of Infection (Deadline: 30 April 2024)
- Mesenchymal Stromal and Immune Cells’ Involvement in Human Diseases and Their Treatment (Deadline: 30 April 2024)
- Mitochondrial Dysfunction in Autoimmune Diseases (Deadline: 30 April 2024)
- New Challenges in Rheumatoid Arthritis (Deadline: 30 April 2024)
- Molecular Research in Sarcoidosis and Granuloma (Deadline: 30 April 2024)
- Molecular Mechanisms and Treatment of Allergic Reactions (Deadline: 15 May 2024)
- Molecular Mechanisms of Primary Graft Dysfunction and Acute Rejection in Solid Organ Transplantation (Deadline: 30 May 2024)
- Immune Modulation of Macrophages 2.0 (Deadline: 30 May 2024)
- Molecular Research of Hepatitis C Virus Infection (Deadline: 30 May 2024)
- Molecular Research and Immunohistology of Contact Dermatitis (Deadline: 30 May 2024)
- Molecular Mechanism and Treatment of Allergic Asthma (Deadline: 30 May 2024)
- Role of Extracellular Vesicles in Immunology (Deadline: 30 May 2024)
- Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy 2.0 (Deadline: 31 May 2024)
- The NLRP3-Inflammasome in Health and Disease 2.0 (Deadline: 31 May 2024)
- The Molecular Mechanisms and Pathogenesis of Food Allergy and New Technologies (Deadline: 31 May 2024)
- Molecular Medicine in Asthma and Allergic Diseases 2.0 (Deadline: 31 May 2024)
- Mechanisms and Means of Immune Modulation in Innate and Adaptive Immunity (Deadline: 31 May 2024)
- Proteomics and Its Applications in Human Biology (Deadline: 31 May 2024)
- Targeting CAR T-cell Therapy: Molecular Research and Its Future Implication (Deadline: 31 May 2024)
- Molecular Advances in Platelet-Related Diseases (Deadline: 31 May 2024)
- Molecular Immunology of Liver Diseases (Deadline: 15 June 2024)
- Immunological and Molecular Networks in the Skin and Skin Diseases (Deadline: 16 June 2024)
- Oxidation and Inflammation in Human Health and Disease (Deadline: 20 June 2024)
- Virus Infection and Infectious Diseases: Unraveling Mechanisms, Innovations, and Therapeutic Strategies (Deadline: 20 June 2024)
- Infectious Agents and Inflammatory Diseases (Deadline: 20 June 2024)
- Novel Insights into Cellular and Molecular Mechanisms of Autoimmune Disease (Deadline: 30 June 2024)
- Neutrophil Extracellular Traps (NETs) in Immunity and Diseases 2.0 (Deadline: 30 June 2024)
- New Insights into Immunity and Inflammation in Cardiovascular Diseases (Deadline: 30 June 2024)
- The ETS Transcription Factor Family in Human Diseases (Deadline: 30 June 2024)
- Biological Role of Oxidative Stress in Inflammatory Diseases 2.0 (Deadline: 31 July 2024)
- Fish Immunology 4.0 (Deadline: 31 July 2024)
- Molecular Insights in Rheumatoid Arthritis (Deadline: 25 August 2024)
- Role of NLRP3 Inflammasome in Inflammatory and Immunological Diseases (Deadline: 30 August 2024)
- Innate Immunity in Autoimmune Diseases (Deadline: 31 August 2024)
- Molecular and Cellular Advances in the Tumor Microenvironment and Cancer Immunotherapy (Deadline: 31 August 2024)
- Inflammation in Chronic Disease: Molecular Mechanisms and Signaling Pathways (Deadline: 31 December 2024)
- Long-COVID and Its Complications (Deadline: 4 December 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
